|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52785611
???header.onlineuser??? :
773
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"calderon"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-09 |
Association of biomarkers with response to first-line (1L) vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in advanced head and neck squamous cell carcinoma (HNSCC): Results from KEYVIBE-005
|
Seo;S;Calderon;B;Chou;H-H;Hsu;C-H;Salman;P;Ghiringhelli;F;Ozyilkan;O;Rojas;C, I.;Sendur;M, A. N.;Tourneau, Le;C;Yen;C, J.;Shapira-Frommer;R;Rha;S, Y.;Zhang;Y;Chen;C;Pena;C, E.;Keenan;T;Chen;Y;Dettman;E;Robinson;A, G. |
| 國立成功大學 |
2017-03 |
Complexation and Electronic Communication between Corannulene-Based Buckybowls and a Curved Truxene-TTF Donor
|
Gallego;Maria;Calbo;Joaquin;Calderon;Krick, Rafael M.;Pla;Paula;Hsieh;Ya-Chu;Perez;Emilio, M.;Wu;Yao-Ting;Orti;Enrique;Guldi;Dirk, M.;Martin;Nazario |
| 臺北醫學大學 |
2005 |
Biofeedback Assisted Relaxation Training for Essential Hypertension: Who is Most Likely to Benefit?
|
蔡佩珊; Yucha; C. B.; Tsai; P. S.; Calderon; K. S.; Tian; L. |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
